Search results
2 new COVID variants called 'FLiRT' are spreading in the U.S. What are the symptoms?
TODAY via Yahoo News· 15 hours agoThe new "FLiRT" COVID-19 variants, including KP.2, are spreading in the United States. Will there be...
How incentives could better treat stimulant use disorder
Medical Xpress· 22 hours agoAlthough research has been underway for more than three decades to develop medications for people...
Altimmune Inc (ALT) Reports Q1 2024 Financials: A Detailed Review
GuruFocus.com via Yahoo Finance· 21 hours agoThe company is preparing for an End-of-Phase 2 meeting with the U.S. Food and Drug Administration...
Nut recall as "life-threatening" warning issued
Newsweek· 2 days agoA nut recall was issued this week alongside warnings of a possible "life-threatening" allergic reaction. On Wednesday, the U.S. Food and Drug< ...
Do Electrolytes Give You Energy?
Verywell Health via Yahoo News· 4 days agoBicarbonate is vital to your body's pH balance and removing carbon dioxide. Overall, having these electrolytes in balance helps sustain your energy...
BioAtla gets FDA nod for new cancer drug trial By Investing.com
Investing.com· 5 days agoBioAtla, Inc. (NASDAQ:BCAB), a biotechnology firm specializing in the development of antibody...
Catalyst's New CEO Has Big Ideas For The Small Biotech
Investor's Business Daily· 1 day agoProbably 80%, 85% of the requirements to be successful in an orphan condition are common. So, the...
Revolutionary mRNA Cancer Vaccine Shows Immense Promise in First-Ever Human Clinical Trial
SciTechDaily· 24 hours agoIn a first-ever human clinical trial of four adult patients, an mRNA cancer vaccine created at the...
TAR-210 results show 90% recurrence-free survival and 90% complete response in patients with...
WKBN 27 Youngstown· 6 days agoJohnson & Johnson announced today updated results from an open-label, multicenter, multi-cohort Phase 1 study of the safety and efficacy of TAR-210, an intravesical targeted ...
NanoViricides to Participate in the 2024 EF Hutton Annual Global Conference On May 15 in New York...
Morningstar· 1 day ago(NYSE American:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, today announces that Anil R. Diwan, Ph.D., the Company's President
